Stay updated on NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer
Sign up to get notified when there's something new on the NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer page.

Latest updates to the NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer page
- ChecktodayChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1; the study record content remains unchanged.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check21 days agoChange DetectedThe revision label changes from v3.6.6 to v3.7.0, indicating a software version update. This does not modify the study data, navigation, or visible content on the page.SummaryDifference0.0%

- Check43 days agoChange DetectedThe history now shows a new revision v3.6.6 replacing v3.6.5, signaling a published update to the page's version.SummaryDifference0.0%

- Check50 days agoChange DetectedA new version (65) was added to the study history on 2026-08-19/20, updating the Study Status and Contacts/Locations sections; the version dated 2026-05-28 was removed from the history.SummaryDifference0.2%

- Check64 days agoChange DetectedThe page’s revision label changed from v3.6.4 to v3.6.5, signaling a software update to the page without altering study data.SummaryDifference0.0%

- Check78 days agoChange DetectedThe page shows a site revision update from v3.6.3 to v3.6.4, signaling a site-wide update. This change does not alter the content of the trial record or its history entries.SummaryDifference0.0%

Stay in the know with updates to NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer
Enter your email address, and we'll notify you when there's something new on the NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer page.